BLADEX, INC. (BLX): Financial results for Q3 2026

BLADEX, INC. (BLX) furnished an SEC Form 6-K — earnings release. o SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BLADEX, INC. (Registrant) Date: October 28, 2026 By: /s/ Annette van Hoorde de So

Event · Earnings
Also in this documentDividend · regular · $0.6875

Facts are quoted from the filing text and checked against it.

Original reporting
Published Oct 28, 2026, 9:29 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 9:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$BLX
Bullish
high confidence
Mentioned
$BLX
Relevance
8/10
AlphAI data visualization · based on SEC EDGAR 6-K
Decision brief

The 30-second read

$BLXBullishHigh
01

Why it matters

The earnings release provides fresh quantitative data on profitability, asset quality, and capital ratios, informing valuation and risk assessment.

02

Market read

First‑report earnings for a mid‑cap emerging market bank; relevant for investors in regional banking and emerging market exposure.

03

What to watch

Potential exposure to regional credit risk and reliance on government loan contracts.

Relevance 8/10Novelty 8/10Timing: post-market release
AlphAI · Earnings readBLX · 3Q26 · ended September 30, 2026

BLADEX ANNOUNCES NET PROFIT OF $63.2 MILLION FOR THE THIRD QUARTER 2026

✓Strong quarter

Record net interest income, 20% year-over-year total revenue growth, 15% year-over-year profit growth, and 35% year-over-year Credit Portfolio growth offset higher impairment losses, operating expenses, and lower sequential profit.

Revenue
$99.1M
20% y/y · 0% q/q
Commercial Business Segment 3Q26
$91.2M
21% y/y · 2% q/q
EPS · other
$1.48
0% y/y · -16% q/q

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
3Q26 Interest incomeother$215M8%11%
3Q26 Interest expenseother−$135.2M-7%-7%
3Q26 Net Interest Incomeother$79.8M9%18%
3Q26 Fees and commissions, netother$16.3M-30%16%
3Q26 Gain on financial instruments, netother$3M36%237%
3Q26 Other income, netother$100K-29%-83%
3Q26 Total revenuesother$99.1M0%20%
3Q26 Impairment losses on financial instrumentsother−$10.4M-21%-61%
3Q26 Operating expensesother−$25.6M-7%-20%
3Q26 Profit for the periodother$63.2M-5%15%
3Q26 Earnings per Shareother$1.48-16%0%
3Q26 Return on Average Equityother14.2%-127bps-76bps
3Q26 Adjusted ROE excluding other equity instrumentsother15.0%-145bps-7bps
3Q26 Return on Average Assetsother1.8%-21bps-4bps
3Q26 Net Interest Marginother2.30%6bps-2bps
3Q26 Net Interest Spreadother1.73%9bps10bps
3Q26 Efficiency Ratioother25.8%167bps2bps
9M26 Net Interest Incomeother$223.3M–11%
9M26 Total revenuesother$281.1M–12%
9M26 Profit for the periodother$186M–9%
9M26 Earnings per Shareother$4.56–-1%
Credit Portfolio as of September 30, 2026other$16.58B15%35%
Commercial Portfolio as of September 30, 2026other$14.98B15%38%
Treasury Investment Portfolio as of September 30, 2026other$1.61B12%14%
Total assets as of September 30, 2026other$16.48B14%32%
Total equity as of September 30, 2026other$1.79B2%9%
Tier 1 Capital to Risk-Weighted Assets (Basel III – IRB) as of September 30, 2026other16.2%-48bps-196bps
Capital Adequacy Ratio (Regulatory) as of September 30, 2026other14.3%-1bps-145bps
Liquidity Coverage Ratio as of September 30, 2026other148%762bps-2,368bps
Total allowance for losses as of September 30, 2026other$103.6M––

Segments

SegmentRevenueq/qy/y
Commercial Business Segment 3Q26Higher average business volumes, strong net interest income, and fee income from off-balance-sheet and structuring business.$91.2M2%21%
Treasury Business Segment 3Q26Higher derivatives intermediation gains were partly offset by increased interest expenses from increased market rates and short-term facilities used to support asset growth.$7.9M-15%5%

Capital returns

  • The Board of Directors approved a quarterly common dividend of $0.6875 per share corresponding to 3Q26.
  • The cash dividend will be paid on November 24, 2026, to shareholders registered as of November 6, 2026.

What drove it

  • Higher average business volumes, including continued short-term lending growth and medium-term transactions, drove record Net Interest Income.
  • Accelerated recognition of deferred fees following early repayments of certain medium-term loans temporarily supported lending yields and Net Interest Margin.
  • Letters of credit and guarantees generated $9.6 million of fee income in 3Q26, supported by increased trade finance activity and higher transaction volumes.
  • The Bank completed four structured transactions during the quarter, bringing the first-nine-month total to thirteen transactions and mobilizing nearly $2.7 billion.
  • A significant short-term transaction with the Government of Panama contributed to Commercial Portfolio expansion.

Concerns

  • Underlying lending spreads continued to face pressure from elevated U.S. Dollar liquidity and intensified competition for high-quality assets across the Region.
  • Impairment losses on financial instruments were $(10.4) million in 3Q26, compared with $(6.5) million in 3Q25.
  • Operating expenses increased 20% year over year to $(25.6) million, mainly reflecting personnel expenses, variable compensation, technology, modernization, and strategic initiatives.
  • Treasury Business Segment profit declined 38% quarter over quarter and 12% year over year to $2.6 million.
  • Tier 1 Capital to Risk-Weighted Assets declined to 16.2% from 18.1% a year ago, while the Regulatory Capital Adequacy Ratio declined to 14.3% from 15.8%.

What to watch

  • The durability of Net Interest Margin after the temporary benefit from accelerated deferred-fee recognition.
  • Whether funding-spread optimization and liquidity management continue to mitigate competitive pressure on underlying lending spreads.
  • Credit-loss provisioning as the Credit Portfolio expands and as reserve coverage is increased for Stage 3 positions.
  • The pace and mix of Commercial Portfolio growth, including the contribution of sovereign and quasi-sovereign exposures.
  • Operating-expense growth associated with talent, technology, modernization, and strategic initiatives.
  • Capital ratios as the Bank deploys capital to support Commercial Portfolio growth.

Balance sheet and cash flow

  • Liquid assets totaled $1,960 million as of September 30, 2026, compared to $1,922 million as of June 30, 2026, and $1,934 million as of September 30, 2025.
  • Customer deposits were $7,964.6 million as of September 30, 2026, compared to $7,934.5 million as of June 30, 2026, and $6,879.7 million as of September 30, 2025.
  • Borrowings and debt were $5,973.9 million as of September 30, 2026, compared to $4,148.9 million as of June 30, 2026, and $3,431.1 million as of September 30, 2025.
  • Total net funding amounted to $14,100 million as of September 30, 2026, representing an increase of 15% compared to $12,270 million a quarter ago, and of 36% compared to $10,372 million a year ago.
  • 90% of total liquid assets represented deposits placed with the Federal Reserve Bank of New York as of September 30, 2026.

Analysis

Bladex reported a strong 3Q26 under IFRS, led by record Net Interest Income of $79.8 million, up 18% year over year and 9% quarter over quarter. Total revenues rose 20% year over year to $99.1 million, while profit for the period increased 15% to $63.2 million. The sequential profit decline to $63.2 million from $66.5 million reflected higher impairment losses and operating expenses, even as revenue held near the prior quarter's level. Basic EPS was $1.48, unchanged from 3Q25 and below $1.77 in 2Q26; the release states that AT1 coupon distributions affect year-over-year EPS comparability following the September 2025 AT1 issuance.

Balance-sheet expansion was substantial. The Credit Portfolio reached $16,584 million, up 35% year over year and 15% quarter over quarter, while the Commercial Portfolio reached $14,976 million, up 38% year over year. The Bank identified a significant short-term Government of Panama transaction as part of this growth. Loans, which were $12,321 million at quarter end, grew 41% year over year. Higher average business volumes drove NII, and accelerated recognition of deferred fees on early repayments of certain medium-term loans added a temporary benefit to lending yields and NIM.

Revenue diversification remained a meaningful contributor. Fees and commissions, net rose 16% year over year to $16.3 million, although they declined 30% sequentially from $23.3 million. Total other income, net was $19.3 million, up 26% year over year, representing 19% of total revenues. Commercial segment revenue increased 21% year over year to $91.2 million and segment profit rose 16% to $60.5 million. Treasury revenue rose 5% year over year to $7.9 million, but Treasury segment profit fell to $2.6 million amid increased interest expenses, short-term funding use, and higher operating expenses.

Margins showed both improvement and pressure. NIM increased 6 basis points sequentially to 2.30%, but was 2 basis points below 3Q25. Net interest spread increased to 1.73% from 1.64% in both comparison periods. Management cited improved funding spreads and efficient liquidity management, while noting persistent competitive pressure on underlying lending spreads from abundant U.S. dollar liquidity and competition for high-quality assets. Operating expenses increased 20% year over year to $(25.6) million, raising the efficiency ratio to 25.8% from 24.1% in 2Q26, although the ratio was essentially flat year over year.

Asset quality remained strong by reported portfolio staging, with 99.1% of the Credit Portfolio in Stage 1 and Stage 2 exposure declining to 0.5%. However, impairment losses increased to $(10.4) million, and total allowance for losses rose to $103.6 million from $93.8 million in the prior quarter, principally due to Stage 1 growth and higher reserve coverage of existing Stage 3 positions. Liquidity was $1,960 million and the Liquidity Coverage Ratio was 148%. Capital remained above stated regulatory minimums, with a 16.2% Tier 1 Basel III Capital Ratio and a 14.3% Regulatory Capital Adequacy Ratio. The Board approved a $0.6875 per-share quarterly common dividend for payment on November 24, 2026. The filing provided no forward financial guidance.

Not in the filing

stated, not guessed
  • Forward revenue, margin, expense, tax-rate, or other financial guidance
  • Prior-period outlook for comparison
  • Cash flow from operations
  • Free cash flow
  • Share repurchases
  • Gross margin
  • Operating income
  • Tax rate
  • Named executive quotes

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

Bladex is a Panama‑based multinational bank serving Latin America and the Caribbean, listed on NYSE under BLX.

Company-level read

Ticker impact

$BLXBullishHigh confidence
Context

Bladex, Inc. reported Q3 2026 net profit of $63.2M, up 15% YoY, with record net interest income and strong fee growth.

Expected impact

likely modest upside as market prices in stronger earnings and higher NII.

Evidence & confidence

Profit growth, record NII, and solid ROE indicate improved fundamentals; no negative guidance disclosed.

Market effects

Banking sector in Latin America may see broader confidence from Bladex's strong results.

Panama and regional investors could view the earnings as a sign of credit and funding stability.

Limited to emerging market banking niche; minimal impact on global indices.

Counterpoint

Despite earnings beat, the AT1 coupon deduction and modest EPS growth could limit upside.

Key entities

  • Annette van Hoorde de Solís

    Chief Financial Officer who signed the filing.

Every BLX earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$BLXMed

Bladex Earnings Call Shows Record Growth Amid Margin Pressure

Banco Latinoamericano de Comercio (BLX) reported Q3 record portfolio growth of $15B, up 15% sequentially and 38% YoY. Net income rose 15% YoY to $63.2M but fell 5% sequentially due to higher costs and provisions. Management expects margin compression and lending spread pressure, citing intense competition for Latin American assets. The company maintained its dividend at $0.6875 per share.

$BLXMedAI 8/10

Bladex Inc (BLX) Q3 2026 Earnings Call Highlights: Record Portfolio and Net Interest

Bladex Inc (BLX) reported Q3 2026 earnings with record commercial portfolio at $15B, up 15% QoQ, and net interest income at $79.8M, up 9% QoQ. Credit quality remained strong, but net interest margin faces pressure. Guidance includes full-year NIM compression to ~2.25%. Loan growth is concentrated in short-term exposures, potentially slowing 2027 growth. The Panama sovereign loan is dilutive to NIM but contributes to NII.

Med

Bladex Grants Panama a Record US$1 Billion Loan

Bladex, a Panama-based trade bank, has granted Panama's government a record US$1 billion loan. The senior loan, announced on 15 September 2026, is for general budgetary purposes. Panama has been diversifying its financing sources amid credit rating pressures.

$BLXHigh

BLADEX, INC. (BLX): Financial results for Q2 2026

BLADEX, INC. (BLX) furnished an SEC Form 6-K — earnings release. o SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BLADEX, INC. (Registrant) Date: July 28, 2026 By: /s/ Annette van Hoorde de Solís